[0001] The present invention refers to a novel class of 2,2,3-trimethylcyclopentane derivatives
possessing an exceptional natural sandalwood oil odour profile. In addition the present
invention refers to fragrance compositions comprising such derivatives.
[0002] Sandalwood oils, in particular East India sandalwood oil, are among the most appreciated
but unfortunately also most scarce perfumery raw materials. As a result, effective
synthetic substitutes that will give the same natural odour, particularly for use
in fine fragrances, have been sought for more than 50 years.
[0003] Compounds based on a saturated ring system, such as 3-methyl-5-(2,2,3-trimethyl-cyclopentyl)pent-3-en-2-ol
(
A), are described, for example, in
EP 0 466 019. According to the description, the odour notes are characterised as being fruity,
flowery, with woody (in particular) side notes. According to
Ernst-Joachim Brunke et al. (in "Fragrance Chemistry, the Science of the Sense of
Smell"; Theimer E.T.; Ed., Academic Press, New York, 1982, pages 424 - 429) saturation of the double bond in the cyclopentene system of 2-methyl-4-(2,2,3-trimethylcyclopent-3-enyl)butan-1-ol
(compound
B wherein R = H) results in a weak dry-woody smell.

[0004] Brunke also observed that the loss of sandalwood odor is detectable after hydrogenation
of 3-methyl-5-(2,2,3-trimethylcyclopent-3-enyl)pentan-2-ol (compound
B wherein R is methyl) and of 4-methyl-6-(2,2,3-trimethylcyclopent-3-enyl)hexan-3-ol
(compound
B wherein R is ethyl).

[0005] Brunke finally stated that to get the fragrance of sandalwood a double bond at C-3
in the ring is necessary, which however can be replaced by a cyclopropane ring, an
ether group or an environment with steric hindrance. With other words, the loss of
the structural feature that enhances the electronic density in the cyclopropane ring
system, which can be either a carbon-carbon double bond or an isolectronic cyclopropane
ring is therefore most likely to bring about a loss or reduction of their typical
sandalwood odour notes.
[0006] Surprisingly, we have now found that certain 2,2,3-trimethylcyclopentane derivatives,
i.e. compounds based on a saturated cyclopentane system, possess an exceptionally
natural sandalwood oil odour.
[0007] Accordingly, the present invention refers in one of its aspects to compounds of formula
1

wherein
R
1 is methyl or ethyl; and
R
2 is hydrogen, methyl or ethyl.
[0008] The compounds of formula
1 may comprise several chiral centres and as such may exist as a mixture of stereoisomers,
or they may be resolved as isomerically pure forms. Resolving stereoisomers adds to
the complexity of manufacture and purification of these compounds, and so it is preferred
to use the compounds as mixtures of their stereoisomers simply for economic reasons.
However, if it is desired to prepare individual stereoisomers, this may be achieved
according to methods known in the art, e.g. preparative HPLC and GC, crystallization
or by departing from chiral starting materials, e.g. starting from enantiomerically
pure or enriched raw materials such as terpenoids, and/or by applying stereoselective
synthesis.
[0009] Thus, the present invention refers in a further aspect to compounds of formula 1
enriched in either a compound of formula 1
R or 1
S, preferably in the ratio from about 1:9 to about 9:1 (
R/
S), e.g. from about 2:3, or about 2:7 to about 6:1, or about 11:1, or pure enantiomers
of compounds of formula
1, namely compounds of formula 1
R or 1
S

wherein R
1 and R
2 have the same meaning as given for formula 1 above.
[0010] Particularly preferred compounds of formula
1 are [1-ethyl-2-[(2,2,3-trimethylcyclopentyl)methyl]cyclopropyl]methanol, [1-methyl-2-[(2,2,3-trimethylcyclopentyl)methyl]cyclopropyl]methanol
and 1-[1-methyl-2-[(2,2,3-trimethylcyclopentyl)methyl]cyclopropyl]ethanol.
[0011] The compounds according to the present invention may be used alone or in combination
with known odorant molecules selected from the extensive range of natural and synthetic
molecules currently available, such as essential oils and extracts, alcohols, aldehydes
and ketones, ethers and acetals, esters and lactones, macrocycles and heterocycles,
and/or in admixture with one or more ingredients or excipients conventionally used
in conjunction with odorants in fragrance compositions, for example, carrier materials,
and other auxiliary agents commonly used in the art.
[0012] The following list comprises examples of known odorant molecules, which may be combined
with the compounds of the present invention:
- essential oils and extracts, e.g. tree moss absolute, basil oil, fruit oils such as
bergamot oil and mandarine oil, myrtle oil, palmarose oil, patchouli oil, petitgrain
oil, jasmine oil, rose oil, sandalwood oil, wormwood oil, lavender oil or ylang-ylang
oil;
- alcohols, e.g. cinnamic alcohol, cis-3-hexenol, citronellol, Ebanol® (3-methyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)-4-penten-2-ol), eugenol, farnesol,
geraniol, Super Muguet™ (6-ethyl-3-methyl-6-octen-1-ol), linalool, menthol, nerol, phenylethyl alcohol, rhodinol,
Sandalore® (5-(2,2,3-trimethyl-3-cyclopentenyl)-3-methylpentan-2-ol), terpineol or Timberol® (1-(2,2,6-trimethylcyclohexyl)hexan-3-ol);
- aldehydes and ketones, e.g. anisaldehyde, α-amylcinnamaldehyde, Georgywood™ (1-(1,2,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethanone), hydroxycitronellal,
Iso E Super® (1-(2,3,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethanone), Isoraldeine® (4-(2,6,6-trimethyl-2-cyclohexenyl)-3-methyl-3-buten-2-one), Hedione® (methyl (3-oxo-2-pentylcyclopentyl)acetate), Lilial® (3-(4-tert-butylphenyl)-2-methylpropanal), maltol, methyl cedryl ketone, methylionone,
verbenone or vanillin;
- ethers and acetals, e.g. Ambrox® (3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan), geranyl methyl ether, rose
oxide or Spirambrene (2,2,3',7',7'-pentamethylspiro(1,3-dioxan-5,2'-norcarane));
- esters and lactones, e.g. benzyl acetate, cedryl acetate, γ-decalactone, Helvetolide® (2-[1-(3,3-dimethylcyclohexyl)ethoxy]-2-methylpropan-1-ol propanoate), γ-undecalactone
or vetivenyl acetate;
- macrocycles, e.g. ambrettolide, ethylene brassylate or Exaltolide® (oxacyclohexadecan-2-one);
- heterocycles, e.g. isobutylquinoline.
[0013] The compounds of the present invention may be used in a broad range of fragrance
applications, e.g. in any field of fine and functional perfumery, such as perfumes,
household products, laundry products, body care products and cosmetics. The compounds
can be employed in widely varying amounts, depending upon the specific application
and on the nature and quantity of other odorant ingredients. The proportion is typically
from 0.001 to 20 weight percent of the application. In one embodiment, compounds of
the present invention may be employed in a fabric softener in an amount of from 0.001
to 0.05 weight percent. In another embodiment, compounds of the present invention
may be used in an alcoholic solution in amounts of from 0.1 to 30 weight percent,
more preferably between 5 and 20 weight percent. However, these values are given only
by way of example, since the experienced perfumer may also achieve effects or may
create novel accords with lower or higher concentrations, e.g., up to about 50 weight
percent based on the fragrance composition.
[0014] The compounds of the present invention may be employed into the fragrance application
simply by directly mixing the fragrance composition with the fragrance application,
or they may, in an earlier step, be entrapped with an entrapment material such as
polymers, capsules, microcapsules and nanocapsules, liposomes, film formers, absorbents
such as carbon or zeolites, cyclic oligosaccharides and mixtures thereof, or they
may be chemically bonded to substrates, which are adapted to release the fragrance
molecule upon application of an external stimulus such as light, enzyme, or the like,
and then mixed with the application.
[0015] Thus, the invention additionally provides a method of manufacturing a fragrance application
and consumer products resulting therefrom. The method comprises the incorporation
therein of a compound of formula
1 as a fragrance ingredient, either by directly admixing the compound to the application
or by admixing a fragrance composition comprising a compound of formula
1, which may then be mixed to a fragrance application, using conventional techniques
and methods. Through the addition of an olfactorily acceptable amount of a compound
of the present invention, the odor notes of a fragrance application will be improved,
enhanced or modified.
[0016] Thus, the invention furthermore provides a method for improving, enhancing or modifying
a fragrance application through the addition thereto of an olfactory acceptable amount
of a compound of formula
1, or a mixture thereof.
[0017] The invention also provides a fragrance application comprising:
- a) as odorant a compound of formula 1 or a mixture thereof; and
- b) a consumer product base.
[0018] As used herein, "fragrance application" means any products, such as fine fragrances,
e.g. eaux de perfume and eaux de toilette; household products, e.g. detergents for
dishwasher, surface cleaner, air freshener; laundry products, e.g. softener, bleach,
detergent; body care products, e.g. after-shave lotion, shampoo, shower gel, shower
and bath salt, hygiene product; and cosmetics, e.g. deodorants, vanishing creams,
comprising an odorant. This list of products is given by way of illustration and is
not to be regarded as being in any way limiting.
[0019] As used herein, "fragrance composition" means any composition comprising at least
one odorant molecule and a diluent conventionally used in conjunction with odorants
in fragrance compositions, such as dipropylenglycol (DPG), isopropylmyristate (IMP),
triethylcitrate (TEC) and alcohol (e.g. ethanol).
[0020] The compounds of the present invention may be prepared according to Scheme 1, starting
from α-campholenic aldehyde of any enantiomer ratio (pure (
R) or (
S) or any mixture of both enantiomers)
via the corresponding dihydroanalogue (2,2,3-trimethylcyclopentylacetaldehyde;
2), as described for example in
EP 0 466 019. The latter may be condensed with an aldehyde or ketone to give the α, β-unsaturated
aldehyde or ketone
3. Reduction of
3 to the corresponding alcohols
4, followed by a cyclopropanation (e.g. using the Simmons-Smith reaction or the Yamamoto
method) affords [2-[(2,2,3-trimethylcyclopentyl)methyl]cyclopropyl]methanols
1 as mixtures of stereoisomers. They may be separated or enriched in one or several
stereoisomers by methodologies known in the art.

[0021] The invention is now further described with reference to the following non-limiting
examples. These examples are for the purpose of illustration only and it is understood
that variations and modifications can be made by one skilled in the art.
[0022] All products described in the Examples were obtained starting from commercially available
qualities of α-campholenic aldehyde of approximately 9:1 or 2:3 (
R/
S) enantiomer ratios. They were transformed into the corresponding enantiomeric mixtures
of known dihydro-α-campholenic aldehyde (
2). Flash chromatography:
Merck silica gel 60 (230 - 400 mesh).
[0023] The reported NMR spectra were measured in CDCl
3; chemical shifts (δ) are reported in ppm downfield from TMS; coupling constants
J in Hz.
Example 1: [1-Ethyl-2-[[(1R)-2,2,3-trimethylcyclopentyl]methyl]cyclopropyl]methanol (1a); e. e. (enantiomeric excess) = 80%
a) 2-Ethyl-4-[(1R)-2,2,3-trimethylcyclopentyl]but-2-enal (3a)
[0024] Sodium methylate (0.75 g, 14 mmol) and butanal (21.6 g, 0.30 mol; dropwise during
2 h) were successively added to a stirred solution of (1
R)-2,2,3-trimethylcyclopentyl-acetaldehyde (
2, e. e. = 80%; 25.0 g, 0.16 mol) in methanol (100 ml) at 5 - 10°C. After additional
18 h stirring at room temperature, acetic acid (3 ml) was added and the reaction mixture
was extracted with MTBE (200 ml). The extract was washed with ice-cold brine (5 x
150 ml), dried (MgSO
4), concentrated
in vacuo and the residue was distilled under reduced pressure to yield unreacted
2 (14 g) and 2-ethyl-4-[(1
R)-2,2,3-trimethylcyclopentyl]but-2-enal (
3a; 95°C/0.08 mbar) which was further purified by flash chromatography (MTBE/hexane
1:15; 8.7 g, 29% yield, colourless liquid; GC/MS: 2 isomeric pairs of enantiomers
3.5 + 91 %).
[0025] Main isomer:
1H NMR: δ 9.35 (s, 1H), 6.45 (t,
J= 7.6, 1H), 2.46 (ddd,
J= 14.4, 7.4, 3.9, 1H), 2.27 (q,
J = 7.6, 2H), 2.12 (ddd,
J = 14.7, 10.6, 7.6, 1 H), 1.87-1.72 (m, 2H), 1.60-1.48 (m, 2H), 1.26-1.19 (m, 2H),
0.98 (t,
J = 7.6, 3H), 0.93 (s, 3H), 0.86 (d,
J = 6.8, 3H), 0.59 (s, 3H).
13C NMR: δ 195.1 (d), 154.9 (d), 145.0 (s), 50.5 (d), 44.9 (d), 42.6 (s), 30.0 (t),
29.9 (t), 28.2 (t), 25.6 (q), 17.3 (t), 14.5 (q), 13.9 (q), 13.3 (q). MS: 208(M
+, 1), 193(2), 165(3), 123(27), 111(23), 110(19), 109(88), 98(51), 95(42), 81(16),
69(100), 67(20), 55(10), 41(49).
b) 2-Ethyl-4-[(1R)-2,2,3-trimethylcyclopentyl]but-2-en-1-ol (4a)
[0026] 2-Ethyl-4-[(1
R)-2,2,3-trimethylcyclopentyl]but-2-enal (
3a; 8.5 g, 41 mmol) was added dropwise within 10 min. to a stirred suspension of sodium
borohydride (1.9 g, 50 mmol) in ethanol (100 ml) at 5 - 10°C. After additional 2 h
stirring at room temperature, the reaction mixture was poured into an ice-cold 0.1
N HCl solution and extracted with MTBE (200 ml). The extract was washed with ice-cold
brine (2 x 100 ml), dried (MgSO
4), concentrated
in vacuo and the residue was distilled under reduced pressure to give 2-ethyl-4-[(1
R)-2,2,3-trimethylcyclopentyl]but-2-en-1-ol (
4a) which was further purified by flash chromatography (MTBE/hexane 1:5; 5.8 g, 68%
yield, colourless liquid; GC/MS: 2 isomeric pairs of enantiomers 0.5 + 88.5%).
[0027] Main isomer:
1H NMR: δ 7.39 (t,
J = 7.2, 1H), 4.04 (q,
J = 1.0, 1H), 2.16 (m, 1H), 2.13 (q,
J = 7.6, 2H), 1.84-1.68 (m, 3H), 1.55-1.36 (m, 3H), 1.22-1.11 (m, 2H), 1.01 (t,
J = 7.6, 3H), 0.89 (s, 3H), 0.83 (d,
J = 6.8, 3H), 0.54 (s, 3H).
13C NMR: δ 140.2 (s), 126.4 (d), 67.0 (t), 51.3 (d), 45.1 (d), 42.3 (s), 30.0 (t), 28.3
(2t), 25.7 (q), 21.0 (t), 14.4 (q), 13.9 (q), 13.2 (q). MS: 210(M
+, 2), 195(3), 177(5), 123(12), 111(34), 110(29), 109(35), 95(45), 82(19), 69(100),
67(18), 57(28), 55(49), 43(17), 41(36).
c) 1-Ethyl-2-[[(1R)-2,2,3-trimethylcyclopentyl]methyl]cyclopropyl]methanol (1a)
[0028] Dibromomethane (2 ml) and acetyl bromide (1 drop) were added to a suspension of ground
mixture of zinc (6.5 g, 0.10 mol) and cuprous bromide (0.86 g, 6 mmol) in diethyl
ether (40 ml). The reaction was started by heating the flask with a heat-gun. After
10 min., a solution of 2-ethyl-4-[(1
R)-2,2,3-trimethylcyclopentyl]but-2-en-1-ol (
4a; 5.0 g, 24 mmol) in diethyl ether (50 ml) was added, followed by more dibromomethane
(total 17.4 g, 0.10 mol; during 6 h) dissolved in the same solvent (30 ml). After
additional 18 h stirring at room temperature, the reaction mixture was diluted with
MTBE (100ml) and filtered over Celite
®. The filtrate was washed with cold 1 N HCl (50 ml) and brine (2 x 100 ml), dried
(MgSO
4), concentrated
in vacuo and the residue (4.8 g) was purified by flash chromatography (MTBE/hexane 1:5) to
afford 1-ethyl-2-[[(1
R)-2,2,3-trimethylcyclopentyl]methyl]cyclopropyl]methanol (
1a, 2.9 g, 54% yield, colourless liquid; GC/MS: 2 main diastereomeric pairs of enantiomers
49.5 + 47.5%).
[0029] Main diastereoisomer (first eluted (GC)):
1H NMR: δ 3.43 (d,
JAB = 11.1, 1H), 3.31 (d,
JAB = 11.1, 1H). 1.96-1.82 (m, 1H), 1.81-1.70 (m, 1H), 1.62-1.29 (m, 5H), 1.28-1.11 (m,
4H), 0.99 (t,
J = 7.4, 3H), 0.85 (s, 3H), 0.83 (d,
J = 6.8, 3H), 0.71-0.59 (m, 1H), 0.50 (s, 3H), 0.43 (dd,
J = 9.0, 4.5, 1 H), -0.08 (dd,
J = 5.7, 4.5, 1 H).
13C NMR: δ 69.3 (t), 51.3 (d), 45.2 (d), 42.2 (s), 30.1 (t), 29.1 (t), 28.3 (t), 27.9
(s), 25.6 (q), 22.1 (d), 22.0 (t), 15.6 (t), 14.4 (q), 13.9 (q), 11.2 (q). MS: 224(M
+, <1), 209(2), 191(4), 137(23), 123(25), 111(28),110(22), 109(55), 96(22), 95(63),
83(26), 81(36), 72(27), 70(100), 69(93), 67(33), 53(14), 55(63), 43(29), 41(58).
[0030] Second major diastereoisomer:
1H NMR: δ 3.49 (d,
JAB = 11.1, 1 H), 3.22 (d,
JAB= 11.1, 1H), 1.96-1.82 (m, 1H), 1.81-1.70 (m, 1H), 1.62-1.29 (m, 5H), 1.28-1.11 (m,
3H), 1.03 (ddd,
J = 13.3, 11.0, 7.1, 1H), 0.99 (t,
J = 7.4, 3H), 0.85 (s, 3H), 0.83 (d,
J = 6.8, 3H), 0.71-0.59 (m, 1H), 0.49 (s, 3H), 0.48 (dd,
J = 9.0, 4.5, 1H), 0.00 (dd,
J = 5.8, 4.5, 1 H).
13C NMR: δ 69.4 (t), 51.8 (d), 45.0 (d), 42.4 (s), 30.2 (t), 29.6 (t), 28.4 (t), 27.0
(s), 25.6 (q), 22.3 (d), 21.4 (t), 16.1 (t), 14.3 (q), 13.9 (q), 11.3 (q). MS: 224(M
+, 1), 209(3), 191(
4), 137(23), 123(26), 111(28), 110(22), 109(53), 96(24), 95(61), 83(27), 81(35), 72(27),
70(100), 69(93), 67(33), 53(14), 55(62), 43(28), 41(57).
[0031] Odour description: sandalwood, natural, dry.
Example 2: [1-Methyl-2-[[(1R)-2,2,3-trimethylcyclopentyl]methyl]cyclopropyl]methanol (1b); e. e. = 80%
[0032] Prepared starting from known 2-methyl-4-(2,2,3-trimethylcyclopentyl)but-2-en-1-ol
(
4b) according to the experimental procedure described in Example 1c as colourless liquid;
GC/MS: 2 main diastereomeric pairs of enantiomers 47 + 50%.
[0033] 1H NMR: δ 3.35 (d,
JAB = 10.9, 1H), 3.34 (d,
JAB = 9.9, 1H), 3.32 (d,
JAB = 9.9, 1 H), 3.30 (d,
JAB = 10.9, 1H), 1.96-1.69 (m, 6H), 1.57-1.37(m, 5H), 1.29-1.05 (m, 7H), 1.14 (s, 3H),
1.13 (s, 3H), 0.86 (2s, 6H), 0.83 (2d,
J = 6.8, 6H), 0.67 (m, 2H), 0.55 (m, 2H), 0.50 (s, 3H), 0.49 (s, 3H), 0.00 (dd,
J = 5.3, 4.5, 1 H), -0.08 (dd,
J = 5.6, 4.2, 1 H).
13C NMR: δ 72.7 (t), 72.6 (t), 51.8 (d), 51.3 (d), 45.1 (d), 45.0 (d), 42.4 (s), 42.1
(s), 30.2 (t), 30.1 (t), 30.0 (t), 29.3 (t), 28.3 (2t), 25.7 (q), 25.6 (q), 22.7 (s),
21.8 (s), 21.4 (d), 21.1 (d), 17.1 (t), 16.5 (t), 15.7 (q), 15.1 (q), 14.4 (q), 14.3
(q), 13.9 (2q). MS: main diastereoisomer (second eluted (GC)): 210(M
+, 1), 195(4), 177(4), 153(18), 137(30), 123(26), 111(32), 110(23), 109(56), 96(24),
95(58), 83(28), 82(25), 81(40), 69(100), 67(30), 58(33), 57(32), 55(58), 43(33), 41(57);
second major diastereoisomer: 210(M
+. 1), 195(5), 177(5), 153(17), 137(29), 123(25), 111(32), 110(24), 109(58), 96(23),
95(59), 83(28), 82(23), 81(41), 69(100), 67(30), 58(33), 57(31), 55(59), 43(34), 41(58).
[0034] Odour description: sandalwood, creamy, very natural, reminiscence of Atlas cedarwood.
Example 3: 1-[1-Methyl-2-[[(1S)-2,2,3-trimethylcyclopentyl]methyl]cyclopropyl]ethanol (1c); e. e. = 25%
[0035] Prepared starting from known 3-methyl-5-(2,2,3-trimethylcyclopentyl)pent-3-en-2-ol
(
4c) according to the experimental procedure described in Example 1c as colourless liquid;
GC/MS: 4 main diastereomeric pairs of enantiomers (19.5 + 21 + 20.5 + 25.5%) separated
by flash chromatography (MTBE/hexane 1:5) into 2 x 2 pair fractions.
[0036] 2 first eluted (FC) pairs of enantiomers:
1H NMR: δ 3.04 (q,
J = 6.4, 1 H), 3.03 (q,
J = 6.4, 1 H), 1.96-1.84 (m, 2H), 1.82-1.70 (m, 2H), 1.57-1.35 (m, 7H), 1.28-1.06 (m,
7H), 1.19 (d,
J = 6.4, 3H), 1.19 (d,
J = 6.4, 3H), 1.03 (s, 3H), 1.02 (s, 3H), 0.86 (s, 3H), 0.86 (s, 3H), 0.83 (2d,
J = 6.8, 3H), 0.67-0.57 (m, 2H), 0.50 (s, 3H), 0.49 (s, 3H), 0.48-0.42 (m, 2H), -0.03
(dd,
J = 5.4, 4.6, 1 H), -0.11 (dd,
J = 5.5, 4.6, 1 H).
13C NMR: δ 76.4 (d), 76.1 (d), 51.9 (d), 51.4 (d), 45.2 (d), 45.0 (d), 42.4 (s), 42.2
(s), 30.2 (t), 30.1 (t), 30.0 (t), 29.5 (t), 28.4 (t), 28.3 (t), 25.7 (q), 25.7 (s),
25.6 (q), 24.8 (s), 23.0 (d), 22.5 (d), 19.1 (q), 19.1 (q), 17.0 (t), 16.5 (t), 14.4
(q), 14.3 (q), 13.9 (q), 13.9 (q), 12.1 (q), 11.6 (q). MS: 224(M
+, <1), 206(1), 191(5), 165(5), 137(12), 123(16), 111(23), 110 (20), 109(43), 96(20),
95(52), 85(22), 82(22), 81(31), 72(63), 70(100), 69(78), 57(24), 55(48), 43(52), 41(48).
[0037] 2 last eluted (FC) pairs of enantiomers:
1H NMR: δ 2.97 (q,
J = 6.3, 1H), 2.96 (q,
J = 6.3, 1H), 1.95-1.82 (m, 2H), 1.80-1.70 (m, 2H), 1.57-1.29 (m, 7H), 1.28-1.09 (m,
7H), 1.19 (d,
J = 6.3, 3H), 1.19 (d,
J = 6.3, 3H), 1.04 (s, 3H), 1.03 (s, 3H), 0.86 (s, 3H), 0.85 (s, 3H), 0.83 (2d,
J = 6.8, 6H), 0.55-0.50 (m, 4H), 0.50 (s, 3H), 0.48 (s, 3H), -0.01 (m, 1H), -0.07 (m,
1H).
13C NMR: δ 76.5 (d), 76.4 (d), 51.7 (d), 51.3 (d), 45.2 (d), 45.0 (d), 42.4 (s), 42.2
(s), 30.2 (t), 30.1 (t), 29.7 (t), 29.0 (t), 28.4 (t), 28.2 (t), 25.9 (s), 25.7 (q),
25.6 (q), 25.0 (s), 21.2 (d), 20.6 (d), 19.3 (q), 19.2 (q), 18.8 (t), 18.3 (t), 14.4
(q), 14.2 (q), 13.9 (q), 13.9 (q), 12.1 (q), 11.4 (q). 224(M
+, <1), 206(1), 191(4), 165(3), 137(12), 123(13), 111(19), 110 (16), 109(36), 96(17),
95(45), 85(18), 82(19), 81(27), 72(48), 70(100), 69(67), 57(20), 55(43), 43(45), 41(42).
[0038] Odour description: sandalwood, woody, balsamic.
Example 4: Floral-woody composition for a feminine fine fragrance
[0039]
| Ingredient |
parts by weight |
| Cepionate® (methyl 2-(3-oxo-2-pentylcyclopentyl)acetate) |
150 |
| Cosmone™ ((Z)-3-methylcyclotetradec-5-enone) |
20 |
| Cyclohexal (4-(4-hydroxy-4-methylpentyl)cyclohex-3-enecarbaldehyde) |
75 |
| Dipropylene glycol |
19 |
| Ethylene brassylate |
90 |
| Florol® (2-isobutyl-4-methyltetrahydro-2H-pyran-4-ol) |
55 |
| Linalyl acetate |
45 |
| Myraldene™ (4-(4-methylpent-3-enyl)cyclohex-3-enecarbaldehyde) |
8 |
| Nirvanolide™ ((Z)-13-methyloxacyclopentadec-10-en-2-one) |
100 |
| Peach pure |
1 |
| Pepperwood™ (3,7-dimethylocta-1,6-dien-3-yl dimethylcarbamate) |
20 |
| Phenylethyl alcohol |
20 |
| Radjanol (2-ethyl-4-(2,2,3-trimethylcyclopent-3-enyl)but-2-en-1-ol) |
25 |
| Rose Bulgary oil |
2 |
| Sandela® (3-(5,5,6-trimethylbicyclo[2.2.1]hept-2-yl)-cyclohexan-1-ol & isomers) |
200 |
| Thibetolide (oxacyclohexadecan-2-one) |
40 |
| |
870 |
An addition of 100 parts of [1-methyl-2-[[(1
R)-2,2,3-trimethylcyclopentyl]methyl]-cyclopropyl]methanol (
1b) to this accord makes it more natural and rounder. It enhances the freshness of the
floral rosy accord and helps to develop comfort and sensuality of the fragrance.